Amgen to merge with BMS


anonymous

Guest
Bob will retire shortly after naming Murdo Gordon CEO of the combined companies. Murdo will split the company and divest products like Imlygic, Blincyto, Corlanor and drugs that do not make much revenue to other companies.
 

Murdo will get rid of old slow growing drugs and slim the company down. The question is whether the Biosimilars will be viewed like as growth product.

I can see the Amgen being raided split. He will combine the best products of both companies and have operations in NJ. The dud products will be combined and spun out into a company left in TO.

A new CEO will run that unit and there are rumors it might be Michael Castagna who is both ex Amgen and BMS currently heading up Mannkind. This allows him to be at a bigger company in the CEO role.

His second wife is at Amgen and he will elevated her into a VP or SVP role.
 
amgen was way too late to the PD-1 game and the reason they didn’t become active in it was because they were always going to buy their way in with a merger with BMS.
 
There is no merger. There will be no merger.

S
B
 


Write your reply...